Hybrid Laparoscopic and Robotic Hepatopancreaticoduodenectomy for Cholangiocarcinoma

  • Eui Hyuk Chong
  • Sung Hoon ChoiEmail author
Multimedia Article



Combined hepatic resection and pancreaticoduodenectomy is the treatment of choice for patient with extensive horizontal-spreading cholangiocarcinoma involving both the perihilar bile duct and the intrapancreatic distal bile duct.1, 2, 3 This surgical procedure is extremely complex, and incurs a high risk of postoperative morbidity and mortality.4 However, in recent years, this complicated high-risk operation can be safely performed in well-selected patients.5 However, as we know, none of these operations have been reported as minimally invasive surgery.

Patient and Methods

A 73-year-old female presented with jaundice and was diagnosed with cholangiocarcinoma. The preoperative image studies revealed a 4.3-cm-long diffuse, infiltrative cholangiocarcinoma from the hilar bile duct to the intrapancreatic bile duct without major vascular invasion. The patient was scheduled to undergo left hepatectomy with caudate lobectomy and pancreaticoduodenectomy to obtain a free resection margin. In order to maximize the efficiency of each surgical modality, we designed a hybrid method of laparoscopic resection and robotic reconstruction for this complicated surgery with a long operation time. A 12-mm port was placed at the subxiphoid area, which was utilized for laparoscopic CUSA during the liver resection. Three 12-mm ports around the umbilicus and an 8-mm robotic port at the right flank were placed. In the resection phase, pancreaticoduodenectomy was performed first, followed by hilar dissection and liver resection in en bloc manner. Here, a hanging maneuver was helpful for the complete resection of the caudate lobe in environment with the large specimen attached. In reconstruction phase, the right flank 8-mm port and the left side 12-mm port (using the double docking technique) were used for docking of two robotic working arms.


The total operation time was 510 min, and the estimated blood loss was 350 mL without transfusion. The patient’s postoperative recovery was smooth, except for a mild fever due to cystitis, and she was discharged on the 16th postoperative day. Permanent pathologic examination revealed a disease-free proximal bile duct margin, but a metastasis was discovered in one regional lymph node metastasis from 18 retrieved lymph nodes. The patient is receiving adjuvant gemcitabine chemotherapy and regular surveillance. We performed two consecutive cases and the perioperative outcomes were summarized in the attached video.


Hepatopancreaticoduodenectomy has a long operative time, involves complicated anatomical structures and difficulty of R0 resection, and it is a remaining frontier of minimally invasive surgery. However, we expect that highly selected patients can carefully undergo minimally invasive surgery if the advantages of the currently available surgical methods are well utilized.


Hepatopancreaticoduodenectomy Cholangiocarcinoma Minimally invasive Robotic Laparoscopic 



The authors would like to express special thanks to Min Jung Kim (medical student, CHA medical University, Seongnam, Republic of Korea) for her help with the illustration.

Author Contribution

- Substantial contributions to the conception or design of the work or the acquisition, analysis, or interpretation of data for the work: E H C, S H C.

- Drafting the work or revising it critically for important intellectual content: E H C, S H C.

- Final approval of the version to be published: E H C, S H C.

- Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved: E H C, S H C.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Supplementary material

11605_2019_4242_MOESM1_ESM.wmv (103.4 mb)
ESM 1 (WMV 105850 kb)


  1. 1.
    Hirono S, Tani M, Kawai M, Ina S, Uchiyama K, Yamaue H. Indication of hepatopancreatoduodenectomy for biliary tract cancer. World J Surg 2006;30(4):567–573; discussion 574–565.CrossRefGoogle Scholar
  2. 2.
    Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, Nagino M. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg 2012;256(2):297–305.CrossRefGoogle Scholar
  3. 3.
    Addeo P, Oussoultzoglou E, Fuchshuber P, Rosso E, Nobili C, Langella S, Jaeck D, Bachellier P. Safety and outcome of combined liver and pancreatic resections. Br J Surg 2014;101(6):693–700.CrossRefGoogle Scholar
  4. 4.
    Tran TB, Dua MM, Spain DA, Visser BC, Norton JA, Poultsides GA. Hepato-pancreatectomy: how morbid? Results from the national surgical quality improvement project. HPB (Oxford) 2015;17(9):763–769.CrossRefGoogle Scholar
  5. 5.
    Aoki T, Sakamoto Y, Kohno Y, Akamatsu N, Kaneko J, Sugawara Y, Hasegawa K, Makuuchi M, Kokudo N. Hepatopancreaticoduodenectomy for Biliary Cancer: Strategies for Near-zero Operative Mortality and Acceptable Long-term Outcome. Ann Surg 2018;267(2):332–337.CrossRefGoogle Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2019

Authors and Affiliations

  1. 1.Division of Hepatobiliary and Pancreas, Department of Surgery, CHA Bundang Medical CenterCHA UniversitySeongnam-siSouth Korea

Personalised recommendations